Country: Suður-Afríka
Tungumál: enska
Heimild: South African Health Products Regulatory Authority (SAHPRA)
Lennon
INDICATIONS [/za_1148.html#1] [/za_1148.html#1] [/za_1148.html#1] CONTRA-INDICATIONS [/za_1148.html#1] [/za_1148.html#1] DOSAGE [/za_1148.html#1] [/za_1148.html#1] SIDE-EFFECTS [/za_1148.html#1] [/za_1148.html#1] [/za_1148.html#1] PREGNANCY [/za_1148.html#1] [/za_1148.html#1] OVERDOSE [/za_1148.html#1] IDENTIFICATION [/za_1148.html#1] [/za_1148.html#1] PATIENT INFORMATION GASTRON TABLETS GASTRON SYRUP (SEE INDEX FOR LATEST VERSION) SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): GASTRON TABLETS GASTRON SYRUP (SEE INDEX FOR LATEST VERSION) COMPOSITION: Each tablet contains 2 mg LOPERAMIDE hydrochloride. Each 5 mL of syrup contains 1 mg loperamide hydrochloride. Preservatives: Methylparaben 0,072% m/v Propylparaben 0,008% m/v PHARMACOLOGICAL CLASSIFICATION: A 11.9 Medicines acting on gastro-intestinal tract: Antidiarrhoeals. PHARMACOLOGICAL ACTION: GASTRON is a piperidine derivative. It slows gastro-intestinal motility by effects on the circular and longitudinal muscles of the intestine. It normalises the stool in both chronic and acute diarrhoea. GASTRON is partially absorbed in the gastro-intestinal tract. It undergoes considerable first-pass metabolism in the liver and is excreted mainly in the faeces. INDICATIONS: GASTRON is indicated for the control of acute and chronic diarrhoea. GASTRON controls intestinal transit time in patients with ileostomies, colostomies and other intestinal resections. CONTRA-INDICATIONS: GASTRON should not be used in the treatment of acute infective diarrhoea, and should also not be used when hepatic dysfunction exists, which may result in relative overdosing. GASTRON should not be administered to children under 2 years. It is contra-indicated in patients hypersensitive to the active ingredient and in those in whom inhibition of per Lestu allt skjalið